Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01512251
Title BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications

melanoma

Therapies

Buparlisib + Vemurafenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST